GlassScriptPhysician profile
Brittany Baron
NPI 1881176881
$3,329.86
in general payments reported to CMS, 2019-2025
32 companies · $561 in 2025
The $561 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.22 · 2021: $378 · 2022: $730 · 2023: $1,225 · 2024: $400 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,092 · Education: $93.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,091.88 |
| Education | $93.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,090.28 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $350.56 | 2023-2025 | Gemtesa, Myfembree |
| Astellas Pharma US INC | $250.07 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $227.12 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $197.38 | 2023-2025 | |
| Mylan Pharmaceuticals INC. | $140.52 | 2021-2022 | |
| Coopersurgical, INC. | $110.05 | 2023-2025 | Paragard T 380a, Endosee, Paragard T 380a |
| Myovant Sciences INC. | $104.07 | 2022 | |
| Daiichi Sankyo INC. | $99.81 | 2022-2024 | Injectafer |
| Avion Pharmaceuticals | $77.58 | 2019-2023 | Balcoltra |
| Hologic Sales and Service, LLC | $68.09 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Boston Scientific Corporation | $59.07 | 2023-2024 | Watchman Access System, Wavewriter Alpha Prime 16 |
| Pfizer INC. | $54.81 | 2024-2025 | |
| Urovant Sciences INC | $53.26 | 2022 | |
| Millicent US INC | $44.67 | 2025 | Intrarosa, Femlyv |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $41.93 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.26 | 2023 | |
| Organon LLC | $37.40 | 2023 | Nexplanon |
| Aspira Women'S Health INC | $33.07 | 2022 | |
| Sage Therapeutics, LLC | $31.65 | 2025 | Zurzuvae |
| Axonics, INC. | $27.05 | 2023 | Axonics |
| 180 Medical, INC. | $24.06 | 2021 | |
| Biogen, INC. | $22.95 | 2024 | |
| Lupin INC. | $22.75 | 2021 | |
| Duchesnay USA Incorporated | $19.42 | 2022 | |
| Exact Sciences Corporation | $18.97 | 2024 | Cologuard Collection Kit |
| Avation Medical, INC. | $14.78 | 2025 | Vivally System |
| Shield Therapeutics INC | $14.42 | 2023 | Accrufer |
| Scynexis, INC. | $14.42 | 2022 | |
| Merck Sharp & Dohme LLC | $14.28 | 2021 | |
| Agile Therapeutics, INC. | $13.48 | 2021 | |
| Terumo Medical Corporation | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Baron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.